| Application no. and date | 10184575.8 (espacenet) (Federated) (European Patent Register), 20040408 | | Patent/reg. no. and date | DK/EP 2368553, 20141231 | | Publication date | 20110928 | | Priority no. and date | US 461611 P, 20030408 | | EP pub. no. and date |
EP 2368553 20110928 | | Effective date | | | Applicant/owner | Progenics Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | V1501-016-DK | | Inventor | SANGHVI, Suketu, 1 Hancock Drive
Kendall Park, NJ 08824, US,
Boyd, Thomas,
279 River Road
Grandview, NJ 10960, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/047 (2006.01) , A61K 31/195 (2006.01) , A61K 31/485 (2006.01) , A61K 45/06 (2006.01) , A61K 47/12 (2006.01) , A61K 47/18 (2006.01) , A61K 9/19 (2006.01) | | Title | Lægemiddelsammensætning der omfatter methylnaltrexon | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
